DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Plitidepsin is an investigational drug.
There have been 12 clinical trials for Plitidepsin. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2010.
The most common disease conditions in clinical trials are Neoplasms, Plasma Cell, Multiple Myeloma, and Lymphoma. The leading clinical trial sponsors are PharmaMar, Apices Soluciones S.L., and Institut Bergonié.
Recent Clinical Trials for Plitidepsin
|Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19||Apices Soluciones S.L.||Phase 1|
|Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19||PharmaMar||Phase 1|
|Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide||PharmaMar||Phase 2|